Clinical trial
An OCT-Guided Variable Dosing Regimen With Ranibizumab for the Treatment of…
NCT00373659 · University of Miami, Other · Completed
Key facts
| NCT number | NCT00373659 |
|---|---|
| Title | An OCT-Guided Variable Dosing Regimen With Ranibizumab for the Treatment of Neovascular AMD |
| Official title | Prospective Optical Coherence Tomography (OCT) Imaging of Patients With Neovascular AMD Treated With Intra-Ocular Ranibizumab (Lucentis) (PrONTO) Study |
| Lead sponsor | University of Miami, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Neovascular Age-related Macular Degeneration |
| Intervention type | Drug |
| Interventions | Ranibizumab (Lucentis) |
| Enrollment | 40 |
| Start date | Aug 1, 2004 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Sep 8, 2006 |
| Last update posted | Jun 13, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: